The latest news and stats on sleep apnea and respiratory care from
ResMed, the world's leading tech-driven medical device company. 

The AirTouch F20 with UltraSoft memory foam, our softest mask ever

View the full press kit

Latest news

Latest news

November 21, 2017

SAN DIEGO – November 21, 2017 – CHEST, the publication of the American College of Chest Physicians, has published a ResMed study that shows patient engagement apps significantly improve...

November 17, 2017

A champion of women in leadership, Drexler brings wealth of experience at both commercial-stage and start-up medtech and healthcare companies Also at annual meeting of shareholders, long-serving...

November 15, 2017

SAN DIEGO – November 15, 2017 – In recognition of World COPD Day, ResMed a global leader in COPD and respiratory care treatment, has selected its top five COPD research findings and therapy...

See all news releases

Fast facts - Landing Page

Fast facts

  • 1,300
    CPAP users a day sign up for myAir to self monitor their treatment.
  • +4 MILLION
    people remotely monitored on cloud connected CPAP machines and ventilators every night.
  • +12 MILLION
    lives changed by a ResMed device, mask or accessory.

See all fast facts

In the news

In the news

October 2, 2017
Seeking Alpha
September 14, 2017
San Diego Business Journal

See all articles

Infographics - Landing Page


Learn about respiratory conditions, their effects on our health and communities,
and how ResMed helps millions live and breathe better.


See all infographics

Media resources - Gray, Left - Landing Page

Media resources

Find everything you need.
Ask us for more information.

See all resources

Media contacts - Gray, Right - Landing Page

Media contacts


Alison Graves
(858) 836-6789



Jayme Rubenstein
(858) 836-6798


EMEA, Japan

Juliette Lambert
(33) 646-621-241



Paul McKeon
(61) 2-8884-2596


Questions? Site Feedback?

Email us

Email Alerts - Landing Page

Sign up to receive ResMed news releases when they publish.



ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages